Veozah (fezolinetant) was approved in 2023 by the FDA to treat moderate to severe hot flashes. A similar drug, elinzanetant, ...

CHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women ...

The California legislature wants doctors to get more educated about menopause symptoms and treatment, part of a national ...

Hydrocortisone oral solution (Khindivi) was approved as a replacement therapy for pediatric patients ages 5 years and up with ...

A mom was diagnosed with a cancerous brain tumor and given a year to live after suffering from "strange" symptoms - including ...

While research specifically tying running to hot flashes is slim, it doesn’t seem like a far jump to think that running may ...

Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer ...

When the FDA approved fezolinetant for treating moderate to severe hot flashes in menopausal women, the news made headlines.

Hormone therapy to treat especially troubling symptoms like severe hot flashes and crippling mood swings has been a subject of much debate in recent decades. While many providers who treat menopause ...

A vegan diet rich in soy reduced severe hot flashes by 92% in postmenopausal women, according to a new study published in ...